Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026)
Butterfly Network (BFLY) reported Liabilities and Shareholders Equity of $285.9 million for Q1 2026, down 10.2% on a YoY basis from $318.4 million in Q1 2025, and down 3.58% sequentially from $296.5 million in Q4 2025.
Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $285.9 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 10.2% year-over-year to $285.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 6.55% YoY), and the FY2025 full-year result was $296.5 million, up 15.8% from the prior year.
- Liabilities and Shareholders Equity retreated to $285.9 million in Q1 2026, from $296.5 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $535.4 million in Q1 2022 to a low of $256.1 million in Q4 2024.
- A 5-year average of $344.7 million and a median of $313.3 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity dropped 28.71% in 2023 and rose 15.8% in 2025, its largest moves.
- Tracing BFLY's Liabilities and Shareholders Equity over 5 years: stood at $417.6 million in 2022, then retreated by 27.13% to $304.3 million in 2023, then slipped by 15.84% to $256.1 million in 2024, then gained by 15.8% to $296.5 million in 2025, then fell by 3.58% to $285.9 million in 2026.
- Business Quant data shows BFLY's Liabilities and Shareholders Equity at $285.9 million in Q1 2026, $296.5 million in Q4 2025, and $290.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 13.32 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 37.13 Bn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 6.63 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 31.92 Bn |
| 10 | Butterfly Network | 1.77 Bn | 1.63 Bn | 18.29 Mn | 285.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285.92 Mn |
| Dec 31, 2025 | 296.53 Mn |
| Sep 30, 2025 | 290.00 Mn |
| Jun 30, 2025 | 313.28 Mn |
| Mar 31, 2025 | 318.41 Mn |
| Dec 31, 2024 | 256.08 Mn |
| Sep 30, 2024 | 265.27 Mn |
| Jun 30, 2024 | 273.07 Mn |
| Mar 31, 2024 | 284.29 Mn |
| Dec 31, 2023 | 304.27 Mn |
| Sep 30, 2023 | 334.22 Mn |
| Jun 30, 2023 | 364.59 Mn |
| Mar 31, 2023 | 381.68 Mn |
| Dec 31, 2022 | 417.57 Mn |
| Sep 30, 2022 | 443.26 Mn |
| Jun 30, 2022 | 496.64 Mn |
| Mar 31, 2022 | 535.42 Mn |
| Dec 31, 2021 | 571.97 Mn |
| Sep 30, 2021 | 580.32 Mn |
| Jun 30, 2021 | 631.26 Mn |